Nisa Investment Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Nisa Investment Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,000	Closed	-$6K	–	2136
2020 Q1	$6K	Sell	1,000 -12,200	-92%	-$107K	﹤0.01%	1942
2019 Q4	$161K	Buy	13,200 +13,000	+6,500%	+$142K	﹤0.01%	1360
2019 Q3	$2K	Buy	+200	New	+$2.1K	﹤0.01%	1993
2017 Q1	–	Sell	-5,300	Closed	-$184K	–	1917
2016 Q4	$184K	Hold	5,300	–	–	﹤0.01%	1262
2016 Q3	$130K	Buy	5,300 +5,000	+1,667%	+$125K	﹤0.01%	1302
2016 Q2	$7K	Sell	300 -11,000	-97%	-$252K	﹤0.01%	1827
2016 Q1	$264K	Hold	11,300	–	–	﹤0.01%	1159
2015 Q4	$341K	Hold	11,300	–	–	﹤0.01%	1056
2015 Q3	$449K	Hold	11,300	–	–	0.01%	1014
2015 Q2	$780K	Hold	11,300	–	–	0.01%	868
2015 Q1	$618K	Buy	11,300 +300	+3%	+$14.3K	0.01%	970
2014 Q4	$469K	Hold	11,000	–	–	0.01%	1030
2014 Q3	$351K	Buy	+11,000	New	+$235K	﹤0.01%	1106

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nisa Investment Advisors's AMAG Position: Q2 2020 in Review

Nisa Investment Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 1,000 shares — an estimated $6K sold.

Nisa Investment Advisors first reported a position in AMAG in Q3 2014 and held it in 13 quarters. The position peaked at $780K in Q2 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

Nisa Investment Advisors reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Nisa Investment Advisors sold 1,000 AMAG Pharmaceuticals shares in Q2 2020, an estimated $6K.
Nisa Investment Advisors first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 13 quarters.
Nisa Investment Advisors's AMAG Pharmaceuticals position peaked at $780K in Q2 2015.
119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Nisa Investment Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.